Abstract
Background: Molecular epidemiological approaches provide opportunities to characterize HIV transmission dynamics. We analyzed HIV sequences and virus load (VL) results obtained during routine clinical care, and individual’s zip-code location to determine utility of this approach. Methods: HIV-1 pol sequences aligned using ClustalW were subtyped using REGA. A maximum likelihood (ML) tree was generated using IQTree. Transmission clusters with ≤3% genetic distance (GD) and ≥90% bootstrap support were identified using ClusterPicker. We conducted Bayesian analysis using BEAST to confirm transmission clusters. The proportion of nucleotides with ambiguity ≤0.5% was considered indicative of early infection. Descriptive statistics were applied to characterize clusters and group comparisons were performed using chi-square or t-test. Results: Among 2775 adults with data from 2014–2015, 2589 (93%) had subtype B HIV-1, mean age was 44 years (SD 12.7), 66.4% were male, and 25% had nucleotide ambiguity ≤0.5. There were 456 individuals in 193 clusters: 149 dyads, 32 triads, and 12 groups with ≥ four individuals per cluster. More commonly in clusters were males than females, 349 (76.5%) vs. 107 (23.5%), p < 0.0001; younger individuals, 35.3 years (SD 12.1) vs. 44.7 (SD 12.3), p < 0.0001; and those with early HIV-1 infection by nucleotide ambiguity, 202/456 (44.3%) vs. 442/2133 (20.7%), p < 0.0001. Members of 43/193 (22.3%) of clusters included individuals in different jurisdictions. Clusters ≥ four individuals were similarly found using BEAST. HIV-1 viral load (VL) ≥3.0 log10 c/mL was most common among individuals in clusters ≥ four, 18/21, (85.7%) compared to 137/208 (65.8%) in clusters sized 2–3, and 927/1169 (79.3%) who were not in a cluster (p < 0.0001). Discussion: HIV sequence data obtained for HIV clinical management provide insights into regional transmission dynamics. Our findings demonstrate the additional utility of HIV-1 VL data in combination with phylogenetic inferences as an enhanced contact tracing tool to direct HIV treatment and prevention services. Trans-jurisdictional approaches are needed to optimize efforts to end the HIV epidemic.
Funder
National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases
National Center for Research Resources and the National Center for Advancing Translational Sciences
District of Columbia Center for AIDS Research, an NIH funded program
Subject
Virology,Infectious Diseases
Reference48 articles.
1. Ending the HIV Epidemic: A Plan for the United States;Fauci;JAMA,2019
2. Office of Infectious Disease and HIV/AIDS Policy, HHS (2021, November 24). About Ending the HIV Epidemic in the U.S.: Priority Jurisdictions: Phase 1; Date Last Updated: 3 November 2020, Available online: https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/jurisdictions/phase-one.
3. Centers for Disease Control and Prevention (2021, December 10). CDC Vital Signs. Ending the HIV Epidemic: HIV Treatment Is Prevention, Available online: https://www.cdc.gov/vitalsigns/end-hiv/pdf/vs-0318-end-hiv-H.pdf.
4. Modeling an integrated HIV prevention and care continuum to achieve the Ending the HIV Epidemic goals;Jenness;AIDS,2020
5. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis;Donnell;Lancet Lond Engl.,2010
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献